Level C· Early human research exploring benefitsProspective StudyPubMedOpen access

Chondrogenic and Osteogenic In Vitro Differentiation Performance of Unsorted and Sorted CD34 + , CD146 + , and CD271 + Stem Cells Derived from Microfragmented Adipose Tissue of Patients with Knee Osteoarthritis.

Bagge J., Mahmood H., Janes J., Vomstein K., Blønd L., Hölmich LR.

Prospective Study on Knee Osteoarthritis, Osteoarthritis, published in J Clin Med (2025) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Prospective Study
Journal
J Clin Med (2025)
Country
Switzerland
Reported sample size
—
Source database
PubMed
PMID
40004714
PMCID
PMC11856665
DOI
10.3390/jcm14041184

Abstract (original English)

Background/Objectives : Treatment of knee osteoarthritis (OA) with autologous stem cells from microfragmented adipose tissue (MFAT) has shown promising but varying results. Multiple stem cell types, including CD34 + , CD146 + , and CD271 + stem cells, have been identified within MFAT. Patient-specific heterogeneity in stem cell populations and the content of highly potent cells may be determining factors for a successful treatment outcome. The current study aimed to identify the most promising stem cell type in MFAT to treat OA, focusing on their chondrogenic and osteogenic differentiation performance. Methods: CD34 + , CD146 + , and CD271 + stem cells from the MFAT of eight patients with knee OA were separated using magnetic-activated cell sorting (MACS) and analyzed as subtypes. Unsorted cells were used as a control. Chondrogenic and osteogenic in vitro differentiation were assessed through Safranin-O and H&E staining, pellet size, and qPCR for chondrogenesis, as well as Alizarin Red S staining and qPCR for osteogenesis. Results: CD34 + , CD146 + , and CD271 + stem cells were doubled using MACS. All subtypes were able to undergo osteogenic differentiation with Alizarin Red S staining, revealing a significant increase in calcium deposits of induced cells compared to non-induced controls. CD146 + stem cells showed higher calcium deposition compared to CD34 + , CD271 + , and uns

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research